Vice President, Product Strategy & Marketing

Rocket Pharmaceuticals • Cranbury, NJ

5d • $306,000 - $367,000

About The Position

Create a future where DNA is no longer destiny. Join Rocket Pharma.
Rocket Pharma is a fully integrated, late-stage biotechnology company advancing gene therapies with curative potential for patients with rare and life-threatening diseases. We are a team of creative, compassionate, and driven individuals united by a profound mission of seeking gene therapy cures. Rocket places tremendous value on our people and fosters a collaborative environment where bold ideas thrive and every team member makes a meaningful impact. Our core values guide everything we do: we trust one another, show generosity toward patients, embrace curiosity, and strive to elevate science. Team members receive a competitive total rewards package, including equity participation, 401(k) matching, and excellent health benefits.
Position Summary
The Vice President, Product Strategy & Marketing will lead product strategy and enterprise-wide go-to-market strategy for Rocket’s pioneering rare cardiac AAV gene therapy portfolio. This role steers the development of cross-functionally aligned integrated product strategy for each asset, defines business opportunity and commercial roadmap from early asset shaping through launch and lifecycle, managing the Marketing function and partnering across other Commercial Affairs functions including Market Access, Commercial Operations and Business Analytics, Medical Affairs, Patient Advocacy. This leader will collaborate with other enterprise functions including Regulatory, Manufacturing/Tech Ops, Finance, Legal/Compliance. The VP will work with Chief Commercial and Medical Affairs Officer in evolving and scaling Rocket’s commercial model, drive market development and diagnostic activation, develop ex-US strategy, and ensure launch readiness is built through disciplined, cross-functional planning and operational execution.

Requirements

• Bachelor’s degree required. Advanced degree (MBA, PharmD, PhD, MD, MPH) strongly preferred; significant gene therapy expertise may be considered in lieu of a specific degree requirement.
• 15+ years proven leadership experience in rare disease and/or specialty commercialization with accountability for product strategy, launch readiness, and cross-functional execution in a matrixed environment.
• Expertise in cell and gene therapy (e.g., AAV gene therapies), including center-of-excellence models, patient identification, and launch constraints unique to one-time therapies.
• Track record of enterprise influence - able to lead through ambiguity, align diverse stakeholders, and drive decisions across functions outside of direct reporting lines.
• Strong communication and executive presence; able to synthesize complex inputs into clear recommendations for senior leadership and GPT governance.
• Experience building global and ex-US commercialization roadmaps and translating them into country-level launch approaches.
• Strong strategic and analytical capability: market assessment, competitive strategy, forecasting, business case development, and scenario planning for pipeline assets.
• Operational rigor in late-stage launch planning: governance, milestones, risk management, and readiness across supply, distribution, patient services, and field enablement.
• People leadership experience with a track record of developing talent, building teams, and establishing scalable processes.

Responsibilities

• Shape the end-to-end commercialization roadmap for novel rare cardiac gene therapies, aligning market opportunity, indications, sequencing, geographies, resourcing needs from development through launch and lifecycle.
• Work with colleagues in Commercial Affairs to evolve Rocket’s gene therapy commercial model (capabilities, structure, partners, field model, patient services, distribution) and scale it appropriately leading up to launch.
• Engage functions beyond Commercial Affairs to support launch readiness across the organization (e.g., Tech Ops/Manufacturing, Quality, Regulatory, Medical, Patient Advocacy, Finance).
• Steer cross-functional global market development strategy for genetic cardiomyopathies, including market shaping to drive disease awareness, diagnosis, genetic testing, and referral pathways.
• Shape global launch strategy and ensure disciplined launch execution planning: positioning, segmentation, target product profile implications, messaging architecture, and go-to-market approach.
• Lead development of ex-US strategy and roadmap (e.g., EU5 and other priority markets), including access considerations, sequencing, partner strategy, and country launch planning.
• Lead late-stage launch readiness “operationalization,” including launch governance, integrated launch plans, timeline/milestone management, and enable cross-functional decision-making forums.
• Lead development and refinement of integrated product strategy for each AAV asset as a member of the GPT, that connect clinical/regulatory/CMC realities with commercial execution and market needs, ensuring cross-functional alignment within commercial affairs and across other functions
• Lead commercialization sub-team at asset level and integrated commercialization input into clinical development strategy to support access and adoption (endpoints, comparators, patient population, trial design considerations, inclusion/exclusion, trial site strategy), lead
• Build business cases for new AAV rare cardiac programs and label expansions, including market opportunity, competitive assessment, risk/uncertainty, and scenario planning, partnering with finance and portfolio management
• Ensure customer insight generation (HCP, patient/caregiver, treatment centers, payers) is built into strategy and translated into actionable plans across functions.
• Develop and mentor a high-performing team across product strategy, marketing, market development, and launch readiness; set clear goals, performance standards, and development pathways.
• Represent marketing and market development strategy internally at executive level and externally with key stakeholders as appropriate (KOLs, advocacy, ecosystem partners).
• Ensure all activities adhere to promotional and non-promotional compliance standards, medical/legal review processes, and global ethical/regulatory requirements.

Benefits

• Team members receive a competitive total rewards package, including equity participation, 401(k) matching, and excellent health benefits.
• Rocket offers a competitive total rewards package that may include bonuses (short-term incentives), medical, dental, and vision insurance, life insurance, 401(k) with company match and generous vesting, paid vacation and holidays, global shutdown days between Christmas and New Year’s, and a variety of wellness resources and employee support programs.
• Also, certain positions are eligible for added forms of compensation, such equity awards (long-term incentives).

What This Job Offers

• Job Type: Full-time
• Career Level: Executive